+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Factor VIII"

Rare Hemophilia Factors - Global Strategic Business Report - Product Thumbnail Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2024-2032 - Product Thumbnail Image

Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2024-2032

  • Report
  • August 2024
  • 141 Pages
  • Global
From
Coagulation Protein Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Coagulation Protein Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 137 Pages
  • Global
From
Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 185 Pages
  • Global
From
Hemophilia A -Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia A -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemophilia- Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Acquired Hemophilia A - Pipeline Insight, 2025 - Product Thumbnail Image

Acquired Hemophilia A - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Von Willebrand's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Willebrand's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemorrhagic Shock - Pipeline Insight, 2025 - Product Thumbnail Image

Hemorrhagic Shock - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Factor IX - Pipeline Insight, 2025 - Product Thumbnail Image

Factor IX - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Factor VIII Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor VIII Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemophilia A - Epidemiology Forecast - 2034 - Product Thumbnail Image

Hemophilia A - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Hemostasis Market - Product Thumbnail Image

Hemostasis Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 186 Pages
  • Global
From
Global Hemostasis Analyzers and Reagents 2024-2029 - USA, Europe, Japan - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks - Product Thumbnail Image

Global Hemostasis Analyzers and Reagents 2024-2029 - USA, Europe, Japan - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks

  • Report
  • December 2024
  • Japan, United States, ... Japan, United States, Europe, Global
From
2025 Global Hemostasis Market Database for the US, Europe, Japan - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

2025 Global Hemostasis Market Database for the US, Europe, Japan - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • February 2025
  • Japan, United States, ... Japan, United States, Europe, Global
From
U.S. Hemostasis Analyzers and Reagents 2024-2029 - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks - Product Thumbnail Image

U.S. Hemostasis Analyzers and Reagents 2024-2029 - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks

  • Report
  • December 2024
  • United States
From
North America Hemostasis Analyzers and Reagents 2024-2029 - USA, Canada, Mexico - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks - Product Thumbnail Image

North America Hemostasis Analyzers and Reagents 2024-2029 - USA, Canada, Mexico - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks

  • Report
  • December 2024
  • Canada, Mexico, North America Canada, Mexico, North America
From
2025 Middle East Hemostasis Market Database for 11 Countries - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

2025 Middle East Hemostasis Market Database for 11 Countries - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • February 2025
  • Middle East
From
2025 North America Hemostasis Market Database for the US, Canada, Mexico - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

2025 North America Hemostasis Market Database for the US, Canada, Mexico - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • February 2025
  • Canada, Mexico, North America Canada, Mexico, North America
From
Loading Indicator

The Factor VIII market is a segment of the hematological drugs market, which includes drugs used to treat blood-related disorders. Factor VIII is a protein that helps blood to clot, and is used to treat hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. Factor VIII is typically administered intravenously, and is available in both recombinant and plasma-derived forms. The Factor VIII market is highly competitive, with a number of companies offering products. These include Novo Nordisk, Pfizer, Bayer, CSL Behring, and Shire. Additionally, there are several smaller companies that offer Factor VIII products, such as Octapharma, Kedrion, and Biotest. Show Less Read more